Skip to Main content Skip to Navigation
Journal articles

CDX2 expression in cutaneous metastatic carcinomas and extramammary Paget's Disease.

Viviana Lora 1 Jean Kanitakis 1, *
* Corresponding author
Abstract : BACKGROUND: CDX2 is a gene involved in the regulation of intestinal cell proliferation/differentiation. It is considered specific for enterocytes and has been used for the diagnosis of primary and metastatic colon adenocarcinoma. The aim of this study was to assess the usefulness of CDX2 in the diagnosis of cutaneous metastatic tumors and extramammary Paget's disease. MATERIALS AND METHODS: The immunohistochemical expression of CDX2 was studied in 68 cutaneous metastatic tumors of various origins and 14 specimens of extramammary Paget's disease. RESULTS: CDX2 expression was found in 3/6 metastases of colon adenocarcinoma, 1/1 metastasis of urothelial carcinoma and 1/2 extramammary Paget's disease. CONCLUSION: CDX2 appears to be specific for cutaneous metastases from intestinal and urothelial carcinomas and is a useful diagnostic marker of these tumors. However, its sensitivity is modest, and we advocate its use in conjunction with additional immunohistochemical markers. CDX2 seems useful for the diagnosis of extramammary Paget's disease associated with an underlying colorectal tumor.
Document type :
Journal articles
Complete list of metadatas

Cited literature [19 references]  Display  Hide  Download

https://www.hal.inserm.fr/inserm-00462238
Contributor : Jean Kanitakis <>
Submitted on : Monday, March 8, 2010 - 11:27:16 PM
Last modification on : Thursday, February 8, 2018 - 1:58:21 PM
Long-term archiving on: : Wednesday, November 30, 2016 - 3:25:29 PM

File

 Restricted access
To satisfy the distribution rights of the publisher, the document is embargoed until : jamais

Please log in to resquest access to the document

Identifiers

  • HAL Id : inserm-00462238, version 1
  • PUBMED : 20044613

Collections

HCL | HEH

Citation

Viviana Lora, Jean Kanitakis. CDX2 expression in cutaneous metastatic carcinomas and extramammary Paget's Disease.. Anticancer Research, International Institute of Anticancer Research, 2009, 29 (12), pp.5033-7. ⟨inserm-00462238⟩

Share

Metrics

Record views

234